The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Liu, Long ^a   Yan, Bing ^b   Huang, Junlong ^c   Gu, Qunhao ^d   Wang, Lina ^a   Fang, Meng ^c   Jiao, Jianpeng ^b   Yue, Xiaoqiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CA125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FUCOSE; FUCOSYLTRANSFERASE; GLYCAN DERIVATIVE; LECTIN; TUMOR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; POLYSACCHARIDE;

ADULT; ARTICLE; ATROPHIC GASTRITIS; BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; FOLLOW UP; FUCOSYLATION; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; VALIDATION STUDY; BLOOD; EPISODIC MEMORY; IN VITRO STUDY; METABOLISM; MIDDLE AGED; STOMACH TUMOR;

BIOMARKERS; FEMALE; GASTRITIS, ATROPHIC; HUMANS; IN VITRO TECHNIQUES; MALE; MEMORY, EPISODIC; MIDDLE AGED; POLYSACCHARIDES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84885803283     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077821     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. doi:10.3322/canjclin.55.2.74. PubMed: 15761078.
2. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J, (2000) Clinical significance and prognostic value of CA724 compared with CEA and CAl9-9 in patients with gastric cancel. Dis Markers16: 105-110. doi:10.1155/2000/595492. PubMed: 11381189.
3. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, et al. (1998) The role of serum and gastric juice levels of carcinoembryonic antigen, CA19-9 and CA72-4 in patients with gastric cancer. J Cancer Res Clin Oncol 24: 450-455.
4. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M, (2001) Prognostic value of carcinoembryonic antigen, CA19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 22: 318-322. doi:10.1159/000050633. PubMed: 11553862.
5. Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C, (2002) CEA, CA19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22: 231l-2316.
6. Haga Y, Sakamoto K, Egami H, Yoshimura R, Mori K, et al. (1986) Clinical significance of serum CA125 values in patients with cancers of the digestive system. Am J Med Sci 292: 30-34. doi:10.1097/00000441-198607000-00006. PubMed: 3459357.
7. Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, et al. (2008) Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 122: 2301-2309. doi:10.1002/ijc.23364. PubMed: 18214858.
8. Saldova R, Reuben JM, Abd Hamid UM, Rudd PM, Cristofanilli M, (2011) Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. Ann Oncol 22: 1113-1119. doi:10.1093/annonc/mdq570. PubMed: 21127012.
9. de Leoz ML, An HJ, Kronewitter S, Kim J, Beecroft S, et al. (2008) Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers 25: 243-258. doi:10.1155/2008/515318. PubMed: 19126968.
10. Kim YG, Jeong HJ, Jang KS, Yang YH, Song YS, et al. (2009) Rapid and high-throughput analysis of N-glycans from ovarian cancer serum using a 96-well plate platform. Anal Biochem 391: 151-153. doi:10.1016/j.ab.2009.05.015. PubMed: 19457428.
11. Lattová E, McKenzie EJ, Gruwel ML, Spicer V, Goldman R, et al. (2009) Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer. Rapid Commun Mass Spectrom 23: 2983-2995. doi:10.1002/rcm.4202. PubMed: 19685473.
12. Ishizuka A, Hashimto Y, Naka R, Kinoshita M, Kakehi K, et al. (2008) Accumulation of free complex-type N-glycans in MKN7 and MKN45 stomach cancer cells. Biochem J 413: 227-237. doi:10.1042/BJ20071562. PubMed: 18399796.
13. Fang M, Zhao YP, Zhou FG, Lu LG, Qi P, et al. (2010) N-glycan based models improve diagnostic efficacies in HBV-related hepatocellular carcin AJCC cancer staging manual oma. Int J Cancer 127: 148-159. doi:10.1002/ijc.25030. PubMed: 19904744.
14. Edge SB, Byrd DR, Compton CC, et al. 7th1 ed. New York: Springer-Verlag, 2009: 117-126.
15. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, et al. (2004) Noninvasive diagnosis of liver cirrhosis using DNA sequencer based total serum protein glycomics. Nat Med 10: 429-434. doi:10.1038/nm1006. PubMed: 15152612.
16. Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, et al. (2007) N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 46: 1426-1435. doi:10.1002/hep.21855. PubMed: 17683101.
17. Kobata A, Amano J, (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumors. Immunol Cell Biol 83: 429-439. doi:10.1111/j.1440-1711.2005.01351.x. PubMed: 16033539.
18. Turnbull JE, Field RA, (2007) Emerging glycomics technologies. Nat Chem Biol 3: 74-77. doi:10.1038/nchembio0207-74. PubMed: 17235338.
19. Miyamoto S, (2006) Clinical applications of glycomic approaches for the detection of cancer and other diseases. Curr Opin Mol Ther 8: 507-513. PubMed: 17243486.
20. Zhao YP, Ruan CP, Wang H, Hu ZQ, Fang M, et al. (2012) Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. Cancer 1: 1-12. PubMed: 21853445.
21. Miyoshi E, Moriwaki K, Nakagawa T, (2008) Biological function of fucosylation in cancer biology. J Biochem 143: 725-729. PubMed: 18218651.
22. Li D, Mallory T, Satomura S, (2001) AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 313: 15-19. doi:10.1016/S0009-8981(01)00644-1. PubMed: 11694234.
23. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, et al. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118: 2803-2808. doi:10.1002/ijc.21728. PubMed: 16385567.
24. Pinho SS, Reis CA, Paredes J, Magalhães AM, Ferreira AC, et al. (2009) The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 18: 2599-2608. doi:10.1093/hmg/ddp194. PubMed: 19403558.